Advertisement

Biobanking pp 77-87 | Cite as

Autopsy Biobanking: Biospecimen Procurement, Integrity, Storage, and Utilization

  • Randy S. Tashjian
  • Ryan R. Williams
  • Harry V. Vinters
  • William H. YongEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1897)

Abstract

An autopsy is a specialized surgical procedure consisting of external and internal examination of a deceased individual for the purposes of documenting abnormalities and determining or confirming medical diagnoses that may have contributed to their death. One of the benefits of an autopsy is the opportunity to collect and store biospecimens for the purposes of biobanking. This chapter outlines the procedures necessary to procure, store, and utilize biospecimens obtained during an autopsy. With the emergence of molecular diagnostics, this chapter also discusses factors that influence the integrity of autopsy biospecimens prior to procurement. These include the postmortem interval, as well as premortem factors such as the patient’s agonal state, biospecimen temperature, and pH.

Key words

Autopsy Biobank Biospecimen Integrity Postmortem interval Agonal state Temperature pH 

Notes

Acknowledgments

This work was supported in part by NIH:NCI P50-CA211015, NIH:NIMH U24 MH100929, the Art of the Brain Foundation, and the Henry E. Singleton Brain Cancer Research Program.

References

  1. 1.
    Marwick C (1995) Pathologists request autopsy revival. JAMA 273(24):1889–1891CrossRefGoogle Scholar
  2. 2.
    Hull MJ, Nazarian RM, Wheeler AE et al (2007) Resident physician opinions on autopsy importance and procurement. Hum Pathol 38(2):342–350CrossRefGoogle Scholar
  3. 3.
    Nolte KB, Taylor DG, Richmond JY (2002) Biosafety considerations for autopsy. Am J Forensic Med Pathol 23(2):107–122CrossRefGoogle Scholar
  4. 4.
    Finkbeiner WE, Ursell PC, Davis RL (2009) Autopsy pathology: a manual and atlas, 2nd edn. Saunders/Elsevier, San Francisco, CAGoogle Scholar
  5. 5.
    Hynd MR, Lewohl JM, Scott HL et al (2003) Biochemical and molecular studies using human autopsy brain tissue. J Neurochem 85(3):543–562CrossRefGoogle Scholar
  6. 6.
    Lee J, Hever A, Willhite D et al (2005) Effects of RNA degradation on gene expression analysis of human postmortem tissues. FASEB J 19(10):1356–1358CrossRefGoogle Scholar
  7. 7.
    Blair JA, Wang C, Hernandez D et al (2016) Individual case analysis of postmortem interval time on brain tissue preservation. PLoS One 11(3):e0151615.  https://doi.org/10.1371/journal.pone.0151615CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Yong WH, Dry SM, Shabihkhani M (2014) A practical approach to clinical and research biobanking. Methods Mol Biol 1180:137–162CrossRefGoogle Scholar
  9. 9.
    Espina V, Mueller C, Edmiston K et al (2009) Tissue is alive: new technologies are needed to address the problems of protein biomarker pre-analytical variability. Proteomics Clin Appl 3(8):874–882CrossRefGoogle Scholar
  10. 10.
    Barton AJ, Pearson RC, Najlerahim A, Harrison PJ (1993) Pre- and postmortem influences on brain RNA. J Neurochem 61(1):1–11CrossRefGoogle Scholar
  11. 11.
    Phang TW, Shi CY, Chia JN, Ong CN (1994) Amplification of cDNA via RT-PCR using RNA extracted from postmortem tissues. J Forensic Sci 39(5):1275–1279CrossRefGoogle Scholar
  12. 12.
    Vennemann M, Koppelkamm A (2010) Postmortem mRNA profiling II: practical considerations. Forensic Sci Int 203(1–3):76–82CrossRefGoogle Scholar
  13. 13.
    Preece P, Cairns NJ (2003) Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Brain Res Mol Brain Res 118(1–2):60–71CrossRefGoogle Scholar
  14. 14.
    Kingsbury AE, Foster OJ, Nisbet AP et al (1995) Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 28(2):311–318CrossRefGoogle Scholar
  15. 15.
    Li JZ, Vawter MP, Walsh DM et al (2004) Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet 13(6):609–616CrossRefGoogle Scholar
  16. 16.
    Tomita H, Vawter MP, Walsh DM et al (2004) Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry 55(4):346–352CrossRefGoogle Scholar
  17. 17.
    Stan AD, Ghose S, Gao XM et al (2006) Human postmortem tissue: what quality markers matter? Brain Res 1123(1):1–11CrossRefGoogle Scholar
  18. 18.
    Mall G, Eisenmenger W (2005) Estimation of time since death by heat-flow Finite-Element model. Part I: Method, model, calibration and validation. Leg Med (Tokyo) 7(1):1–14CrossRefGoogle Scholar
  19. 19.
    Schroeder A, Mueller O, Stocker S et al (2006) The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7(3):1–14Google Scholar
  20. 20.
    Ma MJ, Perry A, Brat DJ (eds) (2010) Biopsy pathology of neurodegenerative disorders in adults. Practical surgical neuropathology: a diagnostic approach. Churchill Livingstone/Elsevier, Philadelphia, pp 566–570Google Scholar
  21. 21.
    Ellison D, Love S et al (2013) Prion diseases. In: Neuropathology: a reference text of CNS pathology, 3rd edn. Mosby/Elsevier, USA, p 676Google Scholar
  22. 22.
    Liu A, Pollard K (2015) Biobanking for personalized medicine. In: Biobanking in the 21st century. Springer International Publishing, Switzerland, pp 55–68CrossRefGoogle Scholar
  23. 23.
    Molina DK (2010) Collection and selection of toxicologic specimens. In: Handbook of forensic toxicology for medical examiners. CRC Press/Taylor & Francis Group, New York, pp 1–6Google Scholar
  24. 24.
    Teunissen CE, Tumani H, Bennett JL et al (2011) Consensus guidelines for CSF and blood biobanking for CNS biomarker studies. Mult Scler Int 2011:246412PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Randy S. Tashjian
    • 1
  • Ryan R. Williams
    • 1
  • Harry V. Vinters
    • 1
    • 2
    • 3
  • William H. Yong
    • 1
    • 2
    • 3
    Email author
  1. 1.Division of Neuropathology, Department of Pathology and Laboratory MedicineDavid Geffen School of Medicine at UCLALos AngelesUSA
  2. 2.Brain Tumor Translational ResourceDavid Geffen School of Medicine at UCLALos AngelesUSA
  3. 3.Jonsson Comprehensive Cancer CenterDavid Geffen School of Medicine at UCLALos AngelesUSA

Personalised recommendations